Metric Analysis: Codexis Inc (CDXS)’s Key Ratios in the Limelight

Nora Barnes

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

In the latest session, Codexis Inc (NASDAQ: CDXS) closed at $2.37 up 0.42% from its previous closing price of $2.36. In other words, the price has increased by $0.42 from its previous closing price. On the day, 0.6 million shares were traded. CDXS stock price reached its highest trading level at $2.4 during the session, while it also had its lowest trading level at $2.31.

Ratios:

For a deeper understanding of Codexis Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.70 and its Current Ratio is at 5.82. In the meantime, Its Debt-to-Equity ratio is 1.24 whereas as Long-Term Debt/Eq ratio is at 1.19.

On May 30, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on May 30, 2024, with a $11 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 13 ’25 when MOORE ALISON sold 6,239 shares for $2.51 per share. The transaction valued at 15,629 led to the insider holds 169,332 shares of the business.

Erbez Georgia sold 6,239 shares of CDXS for $15,629 on Oct 13 ’25. The Chief Financial Officer now owns 70,636 shares after completing the transaction at $2.50 per share. On Oct 13 ’25, another insider, Erbez Georgia, who serves as the Officer of the company, bought 6,239 shares for $2.51 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 213933872 and an Enterprise Value of 216583888. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 3.85. Its current Enterprise Value per Revenue stands at 3.789 whereas that against EBITDA is -4.143.

Stock Price History:

The Beta on a monthly basis for CDXS is 2.58, which has changed by -0.3209169 over the last 52 weeks, in comparison to a change of 0.19736934 over the same period for the S&P500. Over the past 52 weeks, CDXS has reached a high of $6.08, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -6.82%, while the 200-Day Moving Average is calculated to be -16.59%.

Shares Statistics:

For the past three months, CDXS has traded an average of 856.46K shares per day and 637810 over the past ten days. A total of 90.25M shares are outstanding, with a floating share count of 87.58M. Insiders hold about 2.97% of the company’s shares, while institutions hold 77.38% stake in the company. Shares short for CDXS as of 1760486400 were 4754704 with a Short Ratio of 5.55, compared to 1757894400 on 5632430. Therefore, it implies a Short% of Shares Outstanding of 4754704 and a Short% of Float of 5.35.

Earnings Estimates

The dynamic stock of Codexis Inc (CDXS) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.08 and low estimates of -$0.13.

Analysts are recommending an EPS of between -$0.5 and -$0.68 for the fiscal current year, implying an average EPS of -$0.6. EPS for the following year is -$0.62, with 2.0 analysts recommending between -$0.61 and -$0.63.

Revenue Estimates

A total of 7 analysts believe the company’s revenue will be $18.52M this quarter.It ranges from a high estimate of $20.2M to a low estimate of $16.27M. As of . The current estimate, Codexis Inc’s year-ago sales were $12.83MFor the next quarter, 7 analysts are estimating revenue of $24.3M. There is a high estimate of $26.87M for the next quarter, whereas the lowest estimate is $22.21M.

A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $67.7M, while the lowest revenue estimate was $62.82M, resulting in an average revenue estimate of $65.66M. In the same quarter a year ago, actual revenue was $59.34MBased on 6 analysts’ estimates, the company’s revenue will be $79.88M in the next fiscal year. The high estimate is $87.6M and the low estimate is $75.5M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.